Bangladesh - English - DGDA (Directorate General of Drug Administration)

renata limited - choline bitartrate + cobalt sulfate + cyanocobalamin + ferrous sulphate + thiamine mononitrate (b1) - bolus - 18.2 mg + 100 mg + 40 mcg + 200 mg + 50 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

super power pharmaceuticals ltd. - choline bitartrate + cobalt sulfate + cyanocobalamin + ferrous sulphate + thiamine mononitrate (b1) - bolus - 9.1 mg + 50 mg + 20 mg + 100 mg + 25 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

techno drugs ltd. - choline bitartrate + cobalt sulfate + cyanocobalamin + ferrous sulphate + thiamine mononitrate (b1) - bolus - 18.2 mg + 100 mg + 40 mcg + 200 mg + 50 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

novartis (bangladesh) ltd. - choline bitartrate + cobalt sulfate + cyanocobalamin + ferrous sulphate + thiamine mononitrate (b1) - bolus - 18.2 mg + 100 mg + 40 mcg + 200 mg + 50 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

shinil pharma limited - choline bitartrate + cobalt sulfate + cyanocobalamin + ferrous sulphate + thiamine mononitrate (b1) - bolus - 18.2 mg + 100 mg + 40 mcg + 200 mg + 50 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

eskayef pharmaceuticals ltd., narayanganj - choline bitartrate + cobalt sulfate + cyanocobalamin + ferrous sulphate + thiamine mononitrate (b1) - bolus - 18.2 mg + 100 mg + 40 mcg + 200 mg + 50 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

al-madina pharmaceuticals ltd. - choline bitartrate + cobalt sulfate + cyanocobalamin + ferrous sulphate + thiamine mononitrate (b1) - bolus - 18.2 mg + 100 mg + 40 mcg + 200 mg + 50 mg

United States - English - NLM (National Library of Medicine)

global isotopes, llc d/b/a zevacor molecular - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c-11 4 mci in 1 ml - choline c11 injection is indicated for positron emission tomography (pet) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (ct) or magnetic resonance imaging (mri). in these patients, 11 c-choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. suspected prostate recurrence is based upon elevated blood prostate specific antigen (psa) levels following initial therapy. in clinical studies, images were produced with pet/ct coregistration. limitation of use : 11 c-choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer. none. there are no adequate and well controlled studies with choline c11 injection in pregnant women and the fetal radiation dose from a 11 c-choline pet imaging study is unknown. it is not known whether choline c11 injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capa

United States - English - NLM (National Library of Medicine)

washington university school of medicine - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c-11 33.1 mci in 1 ml - choline c 11 injection is indicated for positron emission tomography (pet) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (ct) or magnetic resonance imaging (mri). in these patients, 11 c-choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. suspected prostate recurrence is based upon elevated blood prostate specific antigen (psa) levels following initial therapy. in clinical studies, images were produced with pet/ct coregistration. limitation of u se: 11 c-choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer. none. pregnancy category c. there are no adequate and well controlled studies with choline c 11 injection in pregnant women and the fetal radiation dose from a 11 c-choline pet imaging study is unknown.  it is not known whether choline c 11 injection can cause f

United States - English - NLM (National Library of Medicine)

mayo clinic - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c-11 33.1 mci in 1 ml - choline c 11 injection is indicated for positron emission tomography (pet) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (ct) or magnetic resonance imaging (mri). in these patients, 11 c-choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. suspected prostate recurrence is based upon elevated blood prostate specific antigen (psa) levels following initial therapy. in clinical studies, images were produced with pet/ct coregistration. limitation of u se:   11 c-choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer. none. pregnancy category c. there are no adequate and well controlled studies with choline c 11 injection in pregnant women and the fetal radiation dose from a 11 c-choline pet imaging study is unknown.  it is not known whether choline c 11 injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. animal reproduction studies have not been conducted with 11 c-choline. all radiopharmaceuticals, including choline c 11 injection, have a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development and the magnitude of the radiopharmaceutical dose. assess pregnancy status before administering choline c 11 injection to a female of child bearing potential. choline c 11 injection should be given to a pregnant woman only if clearly needed. choline c 11 injection is not indicated for use in women. it is not known whether choline c 11 injection is excreted in human milk.  because many drugs are excreted in human milk and because of the potential for radiation exposure to nursing infants from choline c 11 injection, nursing mothers should use alternative infant nutrition sources (e.g., stored breast milk or infant formula) and pump and discard breast milk for 8 hours (>10 half lives of radioactive decay for 11 c isotope) after administration of the drug or avoid use of the drug, taking into account the importance of the drug to the mother. the safety and effectiveness of choline c 11 injection have not been established in pediatric patients.